Mia Furebring
- Co-authors
- Jan SjölinKarl MichaëlssonRolf GedeborgPer VengeLena HåkanssonMiklós LipcseyErik EliassonBo Nilsson
- Topics
- Antibiotics Pharmacokinetics and Efficacy (8 papers)Pneumonia and Respiratory Infections (7 papers)Sepsis Diagnosis and Treatment (6 papers)
In The Last Decade
Mia Furebring
24 papers receiving 312 citations
Peers
Comparison fields: 5 of 77
- Epidemiology 143
- Pharmacology 71
- Immunology 71
- Infectious Diseases 53
- Molecular Biology 30
Countries citing papers authored by Mia Furebring
This map shows the geographic impact of Mia Furebring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mia Furebring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mia Furebring more than expected).
Fields of papers citing papers by Mia Furebring
This network shows the impact of papers produced by Mia Furebring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mia Furebring. The network helps show where Mia Furebring may publish in the future.
Co-authorship network of co-authors of Mia Furebring
This figure shows the co-authorship network connecting the top 25 collaborators of Mia Furebring. A scholar is included among the top collaborators of Mia Furebring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mia Furebring. Mia Furebring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 4 | |
| 7 | 1 | |
| 8 | 12 | |
| 9 | 7 | |
| 10 | 3 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 43 | |
| 14 | 23 | |
| 15 | 26 | |
| 16 | 69 | |
| 17 | 12 | |
| 18 | 12 | |
| 19 | 15 | |
| 20 | 38 |
About Mia Furebring
Mia Furebring is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Epidemiology, having authored 26 papers that have together received 314 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Pneumonia and Respiratory Infections (7 papers) and Sepsis Diagnosis and Treatment (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (19 citations), Molecular Medicine (29 citations) and Microbiology (30 citations). Mia Furebring has collaborated with scholars based in Sweden, Italy and Denmark. Frequent co-authors include Jan Sjölin, Karl Michaëlsson, Rolf Gedeborg, Per Venge, Lena Håkansson, Miklós Lipcsey, Erik Eliasson, Bo Nilsson, Anders Larsson and Sten Rubertsson. Their work appears in journals such as Clinical Infectious Diseases, Scientific Reports and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.